Can Septra (trimethoprim/sulfamethoxazole) cause headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Septra Cause Headaches?

Yes, Septra (trimethoprim/sulfamethoxazole) can cause headaches, which are listed as a recognized adverse reaction in the FDA drug label, though they are generally less common than gastrointestinal or allergic skin reactions. 1

Headache as a Direct Adverse Effect

The FDA-approved drug label for sulfamethoxazole/trimethoprim explicitly lists headache among the neurologic adverse reactions associated with this medication. 1 While the most common adverse reactions are gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (rash and urticaria), headache is documented as part of the neurologic side effect profile. 1

Headache as Part of Serious Adverse Reactions

More concerning than simple headache is the potential for drug-induced aseptic meningitis, which presents with severe headache as a cardinal symptom. 2, 3 This serious adverse reaction has been well-documented with TMP/SMX:

  • Aseptic meningitis from TMP/SMX typically presents with headache, fever, and nuchal rigidity, often developing within days to weeks of starting the medication. 2, 3
  • In one case series, a patient developed headaches after only 3 days of TMP/SMX therapy, which progressed to signs of meningeal inflammation. 2
  • Another case documented headaches developing over several weeks of TMP/SMX use, with lumbar puncture revealing elevated leukocyte counts consistent with aseptic meningitis. 3
  • Complete resolution of symptoms and normalization of cerebrospinal fluid occurred within 11 days of discontinuing TMP/SMX. 3

Clinical Context and Risk Assessment

When evaluating headache in a patient taking Septra, clinicians must distinguish between benign medication-related headache and potentially serious aseptic meningitis:

Red Flags Requiring Immediate Evaluation:

  • Fever accompanying the headache 2, 3
  • Nuchal rigidity or meningismus 2
  • Altered mental status, confusion, or difficulty with speech 4
  • Progressive worsening of headache severity 3
  • Associated systemic symptoms (rash, dizziness, weakness) 4

Timing Considerations:

  • Simple headaches may occur at any point during therapy 1
  • Aseptic meningitis typically develops within days to weeks of starting TMP/SMX 2, 3
  • Symptoms resolve within days to weeks after drug discontinuation 3

Management Approach

If a patient on Septra develops isolated mild headache without concerning features, the medication can be continued with close monitoring. 1 However, if headache is severe, progressive, or accompanied by fever, neck stiffness, or altered mental status, immediately discontinue TMP/SMX and perform lumbar puncture to rule out aseptic meningitis. 2, 3

Key Pitfalls to Avoid:

  • Do not dismiss persistent headaches in patients taking TMP/SMX as benign without assessing for meningeal signs 2, 3
  • Do not rechallenge patients who have experienced drug-induced aseptic meningitis with TMP/SMX, as this is a hypersensitivity reaction 3
  • Remember that TMP/SMX is the antibiotic most frequently associated with drug-induced aseptic meningitis 3

Additional Neurologic Adverse Effects

Beyond headache, TMP/SMX can cause other neurologic symptoms including aseptic meningitis, convulsions, peripheral neuritis, ataxia, vertigo, and tinnitus. 1 Psychiatric manifestations such as hallucinations, depression, and nervousness have also been reported. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.